Atrophic glossitis is a clinical condition characterized by the loss of filiform papillae, resulting in a smooth, glossy, and often erythematous tongue surface. Commonly associated with nutritional deficiencies—particularly iron, vitamin B12, and folate—it may also be linked to systemic diseases such as anemia, gastrointestinal disorders, and autoimmune conditions. Patients often present with symptoms of tongue soreness, burning sensation, and altered taste. Diagnosis is primarily clinical, supported by laboratory investigations to identify underlying etiologies. Management focuses on addressing the root cause along with symptomatic relief. This case report describes a middle-aged patient presenting with classical features of atrophic glossitis secondary to vitamin B12 deficiency, emphasizing diagnostic evaluation, therapeutic approach, and clinical outcome.
Atrophic glossitis, also referred to as “bald tongue,” is a manifestation of underlying systemic or nutritional abnormalities. It is characterized by the atrophy of lingual papillae, giving the tongue a smooth and shiny appearance. The condition is not a disease in itself but rather a clinical sign pointing toward underlying pathology.
The most common etiological factors include deficiencies of iron, vitamin B12, and folic acid. Other causes include chronic infections, celiac disease, Sjögren’s syndrome, and adverse drug reactions. Patients may present with discomfort, burning sensation (glossodynia), or may remain asymptomatic.
Early recognition of atrophic glossitis is clinically significant, as it may be the first visible sign of systemic deficiency states. Prompt diagnosis and targeted management can lead to complete resolution and prevent long-term complications.
Patient History
A 45-year-old female presented to the outpatient department with complaints of a persistent burning sensation of the tongue for the past 3 months. The discomfort was aggravated by spicy foods and hot beverages. She also reported fatigue, generalized weakness, and occasional dizziness.

The patient noted a gradual change in the appearance of her tongue, describing it as “smooth” and “redder than usual.” There was no history of trauma, tobacco use, or alcohol consumption. Dietary history revealed a predominantly vegetarian diet with irregular intake of vitamin supplements.
There was no history of gastrointestinal disorders, chronic illnesses, or long-term medication use. Family history was non-contributory.
Smooth and glossy with a loss of filiform papillae
Diffusely erythematous, particularly over the dorsal surface
Mild tenderness on palpation
No ulceration, fissures, or white plaques

The rest of the oral mucosa was normal. No angular cheilitis or mucosal lesions were observed. General physical examination revealed pallor but was otherwise unremarkable.
Based on clinical presentation, the following conditions were considered:
Nutritional deficiency glossitis (iron, vitamin B12, folate)
Geographic tongue (benign migratory glossitis)
Oral candidiasis (erythematous type)
Burning mouth syndrome
Lichen planus
The absence of migratory lesions, fungal plaques, or reticular patterns favored a diagnosis of atrophic glossitis.
Laboratory Findings
Comprehensive laboratory evaluation revealed:
Hemoglobin: 9.8 g/dL (low)
Mean corpuscular volume (MCV): Elevated
Serum vitamin B12: Significantly reduced
Serum folate: Within normal limits
Serum ferritin: Normal
Peripheral smear: Macrocytic anemia
These findings were consistent with vitamin B12 deficiency anemia.

Additional Tests
Thyroid function tests: Normal
Blood glucose levels: Normal
Anti-intrinsic factor antibodies: Negative
No evidence of autoimmune gastritis or endocrine abnormalities was found.
Based on clinical features and laboratory findings, the diagnosis was established as:
Atrophic glossitis secondary to vitamin B12 deficiency
The patient was counseled regarding the underlying nutritional deficiency and its systemic implications. Dietary counseling was provided, emphasizing the inclusion of vitamin B12-rich foods and supplementation.
Pharmacological Treatment
Vitamin B12 supplementation:
Intramuscular cyanocobalamin injections were initiated (1000 mcg weekly for 4 weeks, followed by monthly maintenance doses).
Oral multivitamin supplementation:
To support overall nutritional status
Topical management:
Benzydamine mouthwash for symptomatic relief
Avoidance of irritants such as spicy foods

Follow-Up
At 4 weeks:
Reduction in burning sensation
Improved energy levels
Partial restoration of papillae
At 8 weeks:
Significant symptomatic relief
Visible improvement in tongue texture
Hemoglobin levels improving
At 12 weeks:
Near-complete resolution of glossitis
Normalization of vitamin B12 levels
No residual discomfort

Outcome
The patient demonstrated:
Complete symptomatic relief
Restoration of normal tongue morphology
Improved hematological parameters
No recurrence at 6-month follow-up
Atrophic glossitis is an important clinical indicator of systemic disease, particularly nutritional deficiencies. Vitamin B12 plays a crucial role in DNA synthesis and epithelial cell turnover. Deficiency leads to mucosal atrophy, particularly in rapidly dividing tissues such as the lingual epithelium.
The hallmark feature is the loss of filiform papillae, resulting in a smooth, erythematous tongue. Patients may experience burning sensation, dysgeusia, or hypersensitivity.
Etiology and Risk Factors
Common causes include:
Vitamin B12 deficiency
Iron deficiency anemia
Folate deficiency
Malabsorption syndromes
Chronic alcoholism
Medications (e.g., proton pump inhibitors, metformin)
Autoimmune disorders
Diagnosis is based on:
Clinical appearance of the tongue
Detailed dietary and medical history
Laboratory investigations to identify deficiencies
Biopsy is rarely required unless malignancy or other pathology is suspected.
Correction of nutritional deficiencies
Management of underlying systemic conditions
2. Symptomatic Relief
Topical analgesics
Mouth rinses
Dietary modifications
3. Patient Education
Importance of balanced nutrition
Adherence to supplementation
Regular follow-up
Complications
If left untreated, atrophic glossitis may lead to:
Persistent discomfort
Difficulty in eating
Nutritional deterioration
Neurological complications (in B12 deficiency)
The prognosis is excellent when the underlying cause is identified and treated promptly. Most cases show complete reversal of symptoms and mucosal changes.
Atrophic glossitis is a clinically significant condition that often reflects underlying systemic deficiencies, particularly vitamin B12 deficiency. It presents with a characteristic smooth and erythematous tongue, often accompanied by discomfort and systemic symptoms.
Early diagnosis through clinical recognition and targeted laboratory evaluation is essential. Management focuses on correcting the underlying deficiency and providing symptomatic relief. This case underscores the importance of considering nutritional deficiencies in patients presenting with oral mucosal changes and highlights the favorable outcome with timely intervention.
Green R, Allen LH, Bjørke-Monsen AL, et al. Vitamin B12 deficiency. https://pubmed.ncbi.nlm.nih.gov/25860423/
Langan RC, Zawistoski KJ. Update on vitamin B12 deficiency. https://pubmed.ncbi.nlm.nih.gov/26926814/
Field EA, Allan RB. Review article: oral ulceration—aetiopathogenesis, clinical diagnosis and management. https://pubmed.ncbi.nlm.nih.gov/18422962/
Reamy BV, Derby R, Bunt CW. Common tongue conditions in primary care. https://pubmed.ncbi.nlm.nih.gov/23214284/
Ship JA, Chavez EM, Doerr PA, Henson BS, Sarmadi M. Reversible oral manifestations of systemic disease. https://pubmed.ncbi.nlm.nih.gov/14611518/
Read more such content on @ Hidoc Dr | Medical Learning App for Doctors
1.
Train Eyes so Myopia Doesn't Get Worse? Nurse Intervention for BP Post-Stroke
2.
Characterizing metastatic disease during adaptive therapy by using dynamic biomarkers and mathematical modeling.
3.
Algorithm that predicts pancreatic cancer metastasis could help avoid unnecessary surgeries
4.
C/EBP? works in tandem with MYB to sustain AML cells' oncogenic program.
5.
Nasal therapeutic HPV vaccine could prevent cervical cancer
1.
How Prevident is Revolutionizing Oral Care
2.
Case Study: The Role of JAK Inhibitors in Myeloproliferative Disorders
3.
Getting to Know RDW and SD: How They Relate to Anemia, Inflammation, and More
4.
The Impact of Microadenoma on Hormonal Health
5.
Unraveling the Mysteries of Metastasis: Exploring the Latest Advances in Cancer Research
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
2.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part IV
3.
From Relapse to Remission : Chasing the Invisible and Redefining Long-Term Survival in Adult R/R B-Cell ALL
4.
Efficient Management of First line ALK-rearranged NSCLC - Part VIII
5.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation